Pathwork Diagnostics has appointed David Henner chief medical officer and has named David Craford vice president of commercial operations.
Henner formerly was vice president of oncology at Novacea and Craford was vice president of business development at Affymetrix.
Qiagen has nominated Heino von Prondzynski and Werner Brandt to the company’s supervisory board. They will stand for election at Qiagen’s annual meeting June 20.
Also at that meeting, Franz Wirtz and Heinrich Hornef will retire from their long-held positions on the company’s supervisory board.
Prondzynski was CEO of Roche Diagnostics and a member of Roche’s executive committee and was CEO and general manager at Chiron.
Brandt has been chief financial officer at SAP since 2001 and was a member of SAP’s executive board. He also was CFO of Frenesius Medical Care and formerly worked in finance at Price Waterhouse Coopers.